Osteogenesis imperfecta

Osteogenesis imperfecta (OI) is a heritable connective tissue disorder characterized by bone fragility, skeletal deformities, and growth deficiency.[1][2] Approximately 85–90% of cases result from heterozygous pathogenic variants in COL1A1 or COL1A2, which encode the α1(I) and α2(I) chains of type I collagen—the principal structural protein of bone, dentin, and other connective tissues.[1][3] Remaining cases arise from mutations in genes involved in collagen post-translational modification, processing, mineralization, or osteoblast differentiation.[4][5] Clinical severity spans a continuum from mild (type 1, nondeforming with blue sclerae) through moderate (type 4) and severe progressive deformity (type 3) to perinatally lethal forms (type 2).[6][7] The signature dental radiographic pattern combines generalized jaw osteopenia, thin cortices, and dentinogenesis imperfecta (DI) with bulbous crowns, cervical constrictions, short roots, and progressive pulp obliteration.[8][9] Management is multidisciplinary, centering on bisphosphonate therapy, orthopedic care, and specialized dental treatment.[10][11]

• Current preferred name: Osteogenesis imperfecta (OI).
• Common synonym: Brittle bone disease.[3]
• Historical synonym: Vrolik disease (severe perinatal form); fragilitas ossium.[3]
• Associated dental term: Dentinogenesis imperfecta type I (DI type I)—the form of hereditary dentin dysplasia occurring exclusively in the context of OI, distinguished from DI types II and III caused by DSPP mutations.[8][12]
• Classification: The revised 2023 Nosology of Genetic Skeletal Disorders places OI and related genetically predisposed osteoporoses in Group 26, dividing OI into five clinical types (1–5) combined with the causative gene. The OMIM molecular classification enumerates at least 23 subtypes designated by Roman numerals.[6][13]

• Incidence: Approximately 1 in 15,000–20,000 live births.[1][13]
• Age: Presents from the prenatal period through adulthood; fractures and dental manifestations are most prominent during childhood.[2][7]
• Sex: No sex predilection.[1]
• Inheritance: Predominantly autosomal dominant (80–85% of cases); rare autosomal recessive and X-linked forms account for the remainder.[2][5]
• Jaw involvement: Dental abnormalities are common across all surviving OI types, with DI prevalence ranging from approximately 20% to 48%; more severe skeletal phenotypes (types III/IV) exhibit a higher burden of dental and craniofacial anomalies.[8][14]

Systemic features

• Bone fragility: Fractures from minimal or no trauma are the hallmark, with severity increasing from type 1 through types IV, V, VI, VII, type III, to the perinatally lethal type 2.[1][7]
• Skeletal deformities: Long-bone bowing, short stature, scoliosis/kyphosis, chest wall deformities (pectus excavatum/carinatum), and macrocephaly.[1][2]
• Extraskeletal findings: Blue sclerae (characteristic of type 1; variable in other types), progressive hearing loss, joint hypermobility, easy bruising, and cardiac valvular regurgitation.[1][2]

Craniofacial and oral findings

• Facies: Triangular face with a prominent forehead, flat midface, and reduced lower facial height are common in moderate-to-severe types.[15][16]
• Dentinogenesis imperfecta (DI type I): Teeth exhibit gray-blue to amber-brown discoloration with an opalescent hue; the enamel is structurally normal but chips readily at the dentinoenamel junction because of the dysplastic underlying dentin. The primary dentition is typically more severely affected than the permanent dentition.[9][14][16][17]
• Malocclusion: Class III malocclusion is disproportionately common compared with the general population; anterior and posterior open bites and crossbites are frequent, particularly in types III and IV.[8][15]
• Other dental anomalies: Tooth impaction, ectopic eruption, delayed eruption, and dental agenesis occur, especially in more severe types. Bisphosphonate therapy has been associated with increased prevalence of ectopic teeth and tooth impaction.[8][18]
• Temporomandibular dysfunction: Reported in adults with OI, potentially exacerbated by craniofacial skeletal discrepancies.[16]

Bone density and cortical changes

• Generalized osteopenia of the jaws is a characteristic finding across all OI types, reflecting the systemic reduction in bone mass.[1][11]
• Mandibular cortical thinning: Panoramic radiographs demonstrate significantly reduced mandibular cortical thickness and increased cortical porosity compared with unaffected individuals. The inferior mandibular cortex commonly shows erosive morphology (Klemetti categories C2 and C3).[19]
• Trabecular pattern: Fractal dimension analysis reveals decreased trabecular complexity, most pronounced in the condylar region, indicating altered trabecular microarchitecture.[19]

Effects on teeth

• Teeth affected by DI characteristically display bulbous crowns with cervical constrictions at the crown–root junction, producing a distinctive "thistle-tube" or bell-shaped appearance on periapical and panoramic radiographs.[9][20]

• Short, narrow, and tapered roots are a hallmark radiographic feature of DI type I. Root shortening may be generalized or more pronounced in specific tooth types.[9]

• Progressive pulp obliteration is common and often begins before or shortly after tooth eruption, resulting in partial or complete calcification of pulp chambers and root canals. Obliteration is most prevalent in first molars and increases with patient age. Prolonged bisphosphonate therapy may accentuate pulp obliteration.[9][14][18]
• Taurodontism (enlarged pulp chambers with apically displaced furcations) is an occasional finding, predominantly affecting permanent first molars; its prevalence decreases with age, likely reflecting progressive dentin deposition.[14][17]

• Unerupted, impacted, and ectopically positioned teeth are commonly observed, particularly in types III and IV.[8][18]
• Retention of permanent second molars has been reported in a substantial proportion of adolescents with OI.[17]

Skull and skull base

• Wormian bones (supernumerary intrasutural ossicles) are a characteristic calvarial finding, present in the vast majority of patients with types III and IV and variably in type 1.[11][21]
• Platybasia (flattening of the skull base angle) is common in severe types.[21][22]
• Basilar impression and basilar invagination: Upward migration of the odontoid process relative to skull base reference lines occurs in a substantial minority; true basilar invagination (odontoid protruding into the foramen magnum) is less frequent but clinically significant because of potential cervicomedullary compression.[21][22]
• Calvarial undermineralization may be seen in severe and perinatal lethal forms.[11]

Maxillofacial skeletal relationships

• Cephalometric analysis commonly reveals a hypoplastic maxilla with reduced SNA angle and relative mandibular prognathism, contributing to the skeletal Class III pattern.[15][23]
• Vertical underdevelopment of dentoalveolar structures and anterior open bite are frequent in moderate-to-severe types.[15][16]

Variants by OI type

• Type 1 (mild): Osteopenia and thin cortices with variable Wormian bones; DI may be absent or limited to the primary dentition.[11][17]
• Types III/IV (severe/moderate): Pronounced osteopenia, marked cortical thinning, prominent Wormian bones, platybasia, and a higher prevalence of DI affecting both dentitions, tooth impaction, and skeletal malocclusion.[8][11]
• Type V: Characterized by interosseous membrane calcification and hyperplastic callus formation after fractures; DI is generally absent.[7][8]

Skull base assessment

Medical CT and MRI are indicated when skull base abnormalities are suspected on plain radiographs. CT precisely delineates the relationship of the odontoid process to the foramen magnum and quantifies basilar impression and invagination using standard reference lines (McGregor, McRae).[22] MRI provides complementary evaluation of cerebrospinal fluid flow dynamics, spinal cord signal, and cerebellar tonsillar position, which are critical for determining whether surgical intervention is warranted for cervicomedullary compression.[22][23] CBCT of the craniofacial skeleton may reveal platybasia and Wormian bones but lacks the soft-tissue contrast needed for neurological assessment.[23]

Skeletal survey and DXA

Skeletal radiographs demonstrate the systemic features—long-bone bowing, vertebral compressions, gracile ribs—that support the diagnosis.[1] Dual-energy X-ray absorptiometry (DXA) quantifies bone mineral density and is used to monitor treatment response, though BMD alone underestimates fracture risk in OI because bone quality defects contribute independently to fragility.[1][10]

The combination of generalized jaw osteopenia, thin mandibular cortices, and DI-related dental changes (bulbous crowns, pulp obliteration, short roots) is highly suggestive of OI. However, individual features overlap with other metabolic and genetic bone disorders.

The highest-risk diagnostic pitfall is failing to recognize mild OI (type 1) in a patient presenting with subtle jaw osteopenia and DI limited to the primary dentition, particularly when family history is negative due to de novo mutation. Molecular testing of COL1A1/COL1A2 is the definitive diagnostic step when clinical and radiographic findings are suggestive.[1]

Bone

• In collagen-defective OI (types I–IV), bone histomorphometry reveals reduced cortical width, decreased cancellous bone volume, and diminished trabecular number and thickness with increased bone remodeling activity (high turnover).[1][30]
• Irregular lamellae, excessive woven bone, and abnormal mineralization patterns are common across types.[31]
• Type V OI shows distinctive hyperplastic callus and mesh-like bone lamellation; type VI demonstrates excess osteoid with prolonged mineralization lag time (osteomalacia-like pattern).[7][31][32]

Dentin (DI type I)

• Affected dentin shows sparse, irregularly distributed, and obstructed dentinal tubules with reduced tubule diameter compared with normal dentin.[33][34]
• Ectopic calcified masses within the dentin matrix and disoriented collagen fibrils are characteristic.[34]
• Collagen fibril diameter is reduced, and the normal stiffening gradient between peritubular and intratubular collagen is lost, explaining the reduced mechanical properties and adhesive restoration failure.[33]
• Mantle dentin (the outermost layer) is typically better preserved than circumpulpal dentin, which shows the most severe disorganization.[35]

Radiologic-pathologic correlation

The progressive pulp obliteration seen radiographically corresponds to continued deposition of dysplastic, poorly organized dentin that fills the pulp space.[14][34] The bulbous crown morphology reflects cervical constriction caused by abnormal dentin formation at the cementoenamel junction.[9] Histological DI may be present even when clinical and radiographic signs are absent, detected only on microscopic examination of extracted teeth.[17]

Dental management

• Restorative approach: Full-coverage restorations (stainless steel or zirconia crowns) are recommended for both primary and permanent teeth affected by DI; intracoronal restorations should be avoided because dysplastic dentin promotes structural tooth loss and adhesive failure.[11][36]
• Extractions: Simple extractions can be performed but should be timed to avoid the period immediately before or after intravenous bisphosphonate infusions. Although medication-related osteonecrosis of the jaw (MRONJ) is a theoretical concern, it has not been reported in children with OI receiving bisphosphonates, and the risk in adults with OI is considered low.[11][37][38]
• Orthodontics: Orthodontic treatment is feasible with caution; clear aligners are preferred over fixed appliances given tooth brittleness. Orthognathic surgery is discouraged in severe OI types despite significant skeletal dysplasia.[11][36]

Systemic pharmacologic treatment

• Bisphosphonates (pamidronate, zoledronic acid, risedronate, alendronate) are the mainstay of pharmacologic therapy, consistently increasing bone mineral density. Evidence for fracture reduction is variable: oral risedronate has demonstrated reduced fracture risk in children, while other agents show BMD improvement without conclusive fracture reduction.[11][38][39]
• Emerging therapies including denosumab, teriparatide, and anti-sclerostin antibodies have shown BMD improvements in limited studies but have not gained routine clinical acceptance.[10]

Multidisciplinary care

Optimal management requires coordination among genet